Tibra Equities Europe’s Labcorp LH Stock Holding History

Tibra Equities Europe’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,415	Closed	-$1.86M	–	159
2018 Q1	$1.86M	Buy	+13,415	New	+$1.97M	0.33%	49

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tibra Equities Europe's LH Position: Q2 2018 in Review

Tibra Equities Europe sold out of Labcorp (LH) in Q2 2018, closing a stake of 13,415 shares — an estimated $1.86M sold.

Tibra Equities Europe first reported a position in LH in Q1 2018 and held it in 1 quarter. The position peaked at $1.86M in Q1 2018. 785 funds tracked by Wall St. Rank hold LH as of Q2 2018.

Tibra Equities Europe reported no remaining Labcorp position as of Q2 2018 after selling out during the quarter.
Tibra Equities Europe sold 13,415 Labcorp shares in Q2 2018, an estimated $1.86M.
Tibra Equities Europe first reported a position in Labcorp in Q1 2018 and held it in 1 quarter.
Tibra Equities Europe's Labcorp position peaked at $1.86M in Q1 2018.
785 funds tracked by Wall St. Rank held Labcorp as of Q2 2018.

Based on Tibra Equities Europe's 13F filing for Q2 2018, filed 10 Aug 2018.